CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,827,352 | +331.7% | 1,340,300 | +395.3% | 0.03% | +285.7% |
| Q3 2022 | $1,813,000 | -84.0% | 270,600 | -69.7% | 0.01% | -87.3% |
| Q4 2020 | $11,297,000 | +48.4% | 893,741 | +15.3% | 0.06% | +41.0% |
| Q3 2020 | $7,611,000 | +315.4% | 775,000 | +320.9% | 0.04% | +225.0% |
| Q2 2020 | $1,832,000 | +117.3% | 184,138 | +222.3% | 0.01% | +200.0% |
| Q3 2017 | $843,000 | -79.9% | 57,134 | -86.2% | 0.00% | -86.2% |
| Q3 2016 | $4,190,000 | -7.7% | 414,479 | +2.5% | 0.03% | -6.5% |
| Q2 2016 | $4,542,000 | -5.1% | 404,479 | +15.4% | 0.03% | -16.2% |
| Q1 2016 | $4,786,000 | -42.1% | 350,372 | -36.9% | 0.04% | -35.1% |
| Q2 2015 | $8,264,000 | +3.9% | 555,000 | +5.7% | 0.06% | +5.6% |
| Q1 2015 | $7,954,000 | +19.4% | 525,200 | +5.0% | 0.05% | +14.9% |
| Q4 2014 | $6,660,000 | -1.1% | 500,000 | -6.4% | 0.05% | -7.8% |
| Q3 2014 | $6,736,000 | – | 534,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,817,138 | $30,582,000 | 2.98% |
| SENZAR ASSET MANAGEMENT, LLC | 29,821 | $502,000 | 1.45% |
| INGALLS & SNYDER LLC | 1,337,862 | $22,516,000 | 1.04% |
| Matarin Capital Management, LLC | 316,858 | $5,332,720,000 | 0.39% |
| KNOTT DAVID M | 51,557 | $868,000 | 0.32% |
| PRINCETON CAPITAL MANAGEMENT LLC | 16,582 | $279,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 123,700 | $2,082,000 | 0.10% |
| Spark Investment Management LLC | 97,200 | $1,635,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 941,282 | $15,841,000 | 0.07% |
| Municipal Employees' Retirement System of Michigan | 67,220 | $1,131,000 | 0.06% |